$33.39 0.36 (1.08%)
11:04 EDT PFE Stock Quote Delayed 30 Minutes
Previous Close $33.80
Market Cap 195.30B
PE Ratio 9.27
Volume (Avg. Vol.) 6.84M
Day's Range 33.32 - 33.88
52-Week Range 27.88 - 44.10
Dividend & Yield 1.36 (4.07%)
PFE Stock Predictions, Articles, and Pfizer News
- From InvestorPlace
- From the Web
As pharmaceutical companies rush to manufacture coronavirus vaccine and drugs, it makes sense to hold some potential winners.
PFE stock is not that exciting, but it is on solid ground. Furthermore, the company is on the verge of a breakout on the Covid-19 front.
Shopify, Roku, RingCentral, Pfizer and FedEx were our top stock trades from Wednesday. So, let's look at the charts as we turn to Thursday.
Pfizer (PFE) news for Wednesday concerning one of its vaccines designed to treat the novel coronavirus has PFE stock taking off.
The healthcare sector is meandering and PFE stock is a laggard. Abandon bull trade ideas and embrace bearish ones.
Are you wondering which Dow Jones companies to buy right now? Let's take a closer look at three top names that could belong in a long-term portfolio.
Zoom Video, Apple, Pfizer, Blue Apron and CrowdStrike were our top stock trades for Tuesday. That said, let's look at the charts.
Moderna, a stock that doesn't reside in the Dow Jones Industrial Average, sent the blue chip index soaring to start the week.
Healthcare and technology names lifted broader benchmarks to modest Monday gains as some economies inch toward reopening.
With oil trading higher for a fifth consecutive day and more states embracing the idea of at least reopening some parts of their economies, the major equity averages traded higher on Tuesday, building on the late Monday rally.
PepsiCo, Harley-Davidson, Pfizer and Southwest Airlines were our top stock trades. That said, here's a look at their post-earnings setups.
The major equity averages didn't do much of anything Tuesday even as several big names reported earnings before the opening bell. Fortunately, there was some decent commentary from those companies, albeit cautious, indicating that the U.S. economy could start rebounding in the second half of the year.
Pfizer is working on a coronavirus treatment, but PFE stock may not need that catalyst over the long haul. Here's why.
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
Pfizer (PFE) news for Wednesday includes German approval for a vaccine trials to treat the novel coronavirus boosting PFE stock up.
Monday's big stock charts feature names that may have downside protection in the form of trendline support.
Stocks popped Friday as investors sought coronavirus clarity from the White House and speculated the Fed could cut rates to zero.
Navellier RatingsPowered by Portfolio Grader